Symbiotec Pharmalab IPO
OPENSymbiotec Pharmalab Ltd · Mainboard IPO · N/A
Price Band
₹988
Issue Size
₹1757 Cr
Lot Size
15
GMP UNOFFICIAL
₹275 (27.8%)
Subscription
75.08x
About Symbiotec Pharmalab Ltd & Business Model
Symbiotec Pharmalab Ltd is an established Indian enterprise operating in commercial and industrial sectors. The company delivers specialized solutions, high-grade products, and technology-driven operations tailored to domestic and global market requirements.
Business Operations & Revenue Model
Symbiotec Pharmalab Ltd operates a scalable business model focused on value creation. Revenue is generated through primary product sales, long-term service contracts, B2B distribution networks, and institutional partnerships.
Products & Key Services
1. Core Product Offerings: Engineered for industry standards. 2. Customized Solutions: Designed to meet specific client specifications. 3. Value-Added Services: Technical support and fulfillment services.
Promoters & Corporate Leadership
Symbiotec Pharmalab Ltd is led by experienced promoters with extensive industry track records and strategic governance capabilities.
Objects of the Issue (IPO Objectives)
The company proposes to utilize the Net Fresh Issue proceeds for funding capital expenditure, meeting working capital requirements, prepayment of outstanding borrowings, and general corporate purposes.
IPO Details & Terms
Strengths & Risks
✅ Strengths
- •Established market presence and strong brand recognition.
- •Integrated operational capabilities with focus on quality assurance.
- •Experienced promoter and management team.
⚠️ Risks
- •Fluctuations in raw material pricing could impact operating margins.
- •Intense market competition in operating segments.
Frequently Asked Questions
What is Symbiotec Pharmalab IPO?
Symbiotec Pharmalab IPO is an IPO by Symbiotec Pharmalab Ltd (General sector). Price band is ₹988 with an issue size of ₹1757 Cr.
What is the minimum investment for Symbiotec Pharmalab IPO?
The minimum retail investment for Symbiotec Pharmalab IPO is approximately ₹14,820 (1 lot of 15 shares at the upper price band).
When is the Symbiotec Pharmalab IPO listing date?
Symbiotec Pharmalab IPO is scheduled to list on 01 Sep 2026 on N/A.
What is Symbiotec Pharmalab IPO IPO GMP today?
The latest recorded Grey Market Premium (GMP) for Symbiotec Pharmalab IPO is ₹275 (27.8%). Note that GMP is an unofficial market sentiment indicator and does not guarantee listing price.
Key Dates
IPO Rating
GMP (Grey Market Premium) is an unofficial, unregulated indicator. It does not guarantee the listing price. All IPO information is for educational purposes only. Verify from official SEBI/NSE/BSE sources.